2/5
06:10 am
neup
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Neuphoria Therapeutics (NASDAQ:NEUP) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.